🇺🇸 FDA
Pipeline program

BECLOMETASONE , FLUTICASONE , BUDESONIDE , SALBUTAMOL

PaNaMa 12782

Approved small_molecule active

Quick answer

BECLOMETASONE , FLUTICASONE , BUDESONIDE , SALBUTAMOL for Episodic expiratory wheezing is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Disc Medicine
Indication
Episodic expiratory wheezing
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials